181 related articles for article (PubMed ID: 25325036)
1. Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience.
Kim J; Yoon DH; Park I; Kim S; Park JS; Lee SW; Huh J; Park CS; Suh C
Blood Res; 2014 Sep; 49(3):170-6. PubMed ID: 25325036
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histological features of primary testicular diffuse large B-cell lymphoma: a single center experience in China.
Zhou D; Bao C; Ye X; Zhu L; Zhu J; Li L; Zhu M; Yang X; Zheng Y; Huang X; Xie M; Xie W
Oncotarget; 2017 Dec; 8(68):112384-112389. PubMed ID: 29348832
[TBL] [Abstract][Full Text] [Related]
3. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Mannisto S; Vähämurto P; Pollari M; Clausen MR; Jyrkkiö S; Kellokumpu-Lehtinen PL; Kovanen P; Karjalainen-Lindsberg ML; d'Amore F; Leppä S
Eur J Cancer; 2019 Jul; 115():27-36. PubMed ID: 31082690
[TBL] [Abstract][Full Text] [Related]
4. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
6. Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma.
Ma'koseh M; Tamimi F; Abufara A; Abusalem L; Salama O; Saleh Y; Khader R; Faiyoumi BA; Al-Rwashdeh M; Halahleh K
Cureus; 2021 Aug; 13(8):e16802. PubMed ID: 34513408
[TBL] [Abstract][Full Text] [Related]
7. Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Oh D; Ahn YC; Kim WS; Kim SJ
Cancer Manag Res; 2023; 15():463-474. PubMed ID: 37304895
[TBL] [Abstract][Full Text] [Related]
8. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
[TBL] [Abstract][Full Text] [Related]
9. The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.
Arkenau HT; Chong G; Cunningham D; Watkins D; Agarwal R; Sirohi B; Trumper M; Norman A; Wotherspoon A; Horwich A
Ann Oncol; 2007 Mar; 18(3):541-5. PubMed ID: 17164228
[TBL] [Abstract][Full Text] [Related]
10. Primary Testicular Lymphoma: Single Center Experience.
Shah S; Sreenivasan S; Kancharla P; Khan C; Samhouri Y
Cancer Diagn Progn; 2023; 3(2):139-144. PubMed ID: 36875297
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of prophylactic irradiation to the contralateral testis for patients with advanced-stage primary testicular lymphoma: an analysis of outcomes at a single institution.
Tokiya R; Yoden E; Konishi K; Kamitani N; Hiratsuka J; Koresawa R; Hirose T; Sano F; Tokunaga H; Kondo T; Wada H; Sugihara T
Int J Hematol; 2017 Oct; 106(4):533-540. PubMed ID: 28612278
[TBL] [Abstract][Full Text] [Related]
13. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China.
Chen B; Cao DH; Lai L; Guo JB; Chen ZY; Huang Y; Qiu S; Lin TH; Gou Y; Ma N; Yang L; Liu LR; Wei Q
BMC Cancer; 2020 Mar; 20(1):220. PubMed ID: 32171265
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System.
Hall KH; Valla K; Flowers CR; Cohen JB
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):89-94. PubMed ID: 30528416
[TBL] [Abstract][Full Text] [Related]
15. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
[TBL] [Abstract][Full Text] [Related]
16. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.
Zucca E; Conconi A; Mughal TI; Sarris AH; Seymour JF; Vitolo U; Klasa R; Ozsahin M; Mead GM; Gianni MA; Cortelazzo S; Ferreri AJ; Ambrosetti A; Martelli M; Thiéblemont C; Moreno HG; Pinotti G; Martinelli G; Mozzana R; Grisanti S; Provencio M; Balzarotti M; Laveder F; Oltean G; Callea V; Roy P; Cavalli F; Gospodarowicz MK;
J Clin Oncol; 2003 Jan; 21(1):20-7. PubMed ID: 12506165
[TBL] [Abstract][Full Text] [Related]
17. Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
Eyre TA; Kirkwood AA; Wolf J; Hildyard C; Mercer C; Plaschkes H; Griffith J; Fields P; Gunawan A; Oliver R; Booth S; Martinez-Calle N; McMillan A; Bishton M; Fox CP; Collins GP; Hatton CSR
Br J Haematol; 2019 Oct; 187(2):185-194. PubMed ID: 31222719
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of survival and treatment outcome of patients with primary diffuse large B cell lymphoma in reproductive system].
Yang P; Zhen JF; Pang M; Hu K; Zhao W; Dong F; Tian L; Ke XY; Jing HM
Zhonghua Yi Xue Za Zhi; 2018 May; 98(20):1593-1596. PubMed ID: 29886651
[No Abstract] [Full Text] [Related]
19. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Linassier C; Desablens B; Lefrancq T; Le Prise PY; Harousseau JL; Jacob C; Gandhour C; Haillot O; Lucas V; Leloup R; Escoffre M; Colombat P; Tabuteau S;
Clin Lymphoma; 2002 Dec; 3(3):167-72. PubMed ID: 12521394
[TBL] [Abstract][Full Text] [Related]
20. Single-center experience in the treatment of primary testicular lymphoma.
Mihaljevic B; Vukovic V; Smiljanic M; Milic N; Todorovic M; Bila J; Andjelic B; Djurasinovic V; Jelicic J; Antic D
Oncol Res Treat; 2014; 37(5):239-42. PubMed ID: 24853782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]